Insurance

Private health insurance report 2003-04

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance, 1 July 2003 to 30 June 2004.

Private health insurance report 2004-05

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance, 1 July 2004 to 30 June 2005.

Private health insurance report 2005-06

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance, 1 July 2005 to 1 July 2006.

Private health insurance report 2006-07

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance, 1 July 2006 to 30 June 2007.

Private health insurance report 2007-08

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance, 1 July 2007 to 30 June 2008.

Private health insurance report 2008-09

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance, 1 July 2008 to 30 June 2009.

Private health insurance report 2009-10

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance, 1 July 2009 to 30 June 2010.

Private health insurance report 2010-11

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance, 1 July 2010 to 30 June 2011.

Private health insurance report 2011-12

Report to the Australian Senate on anti-competitive and other practices by health funds and providers in relation to private health insurance, 1 July 2011 to 30 June 2012.

Medical indemnity insurance: sixth monitoring report

In October 2002 the Prime Minister announced that the ACCC would monitor medical indemnity premiums to assess whether they are actuarially and commercially justified.